Irina Ridley

Irina Ridley is an accomplished healthcare executive with extensive experience in Legal, Risk, (Compliance, Privacy, Cybersecurity), Corporate Affairs (Investor Relations, Communications, Public Relations) and Business Development. Prior to joining Aerin, Irina was the Chief Legal Officer and Head of Investor Relations at NeuroPace, Inc., which she led through its initial public offering. Prior to NeuroPace, Irina was Associate General Counsel at Counsyl, Inc. prior to its acquisition by Myriad Genetics and stayed on to oversee the integration efforts post-merger. Irina’s diverse experience spans across life sciences, including Medical Devices, Diagnostics, BioPharma, and Digital Health, as well as leading life sciences consulting engagements at Deloitte US and PricewaterhouseCoopers LLP. Irina received her B.S. from Rensselaer Polytechnic Institute, where she also received her MBA, and her J.D. from Albany Law School.